Rigshospitalet
Copenhagen, 2100, Denmark
NCT Number: NCT04294108
The study aims to identify specific or potential reasons that prolong the length of hospital stay after video-assisted thoracoscopic surgery lobectomy.
The hypothesis is that patients who are still in hospital after video-assisted thoracoscopic surgery lobectomy are associated with prolonged air leak, infection, pneumonia, atrial fibrillation or other complications or social factors.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Copenhagen, 2100, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
•Age < 18 years
Patients have a longer length of hospital stay than the common recommendation.
Time frame: Through study completion, an average of 2 days
Time frame: Up to 30 days
Time frame: Through study completion, an average of 2 days
Patients are scored using a numeric rating scale ranging from 0 (no pain) to 10 (excruciating pain) per day.
Time frame: Duration from postoperative chest tube placement to potential removal, an average of 2 days
The criteria of drain removal is that air leak was consistently below 20 ml/min for at least 12 hours and fluid production was non-bloody and non-chylous without an upper volume limit.
Rigshospitalet, Denmark
Other
Why Are Patients Still in Hospital After Video-Assisted Thoracoscopic Surgery Lobectomy?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04776447
Bronchial Neoplasms, Carcinoma Bronchiogenic Stage III
Alicante, Spain
View Trial DetailsNCT04592523
Anaplastic Lymphoma Kinase, Bronchial Neoplasms
Busan, South Korea
View Trial DetailsNCT06678555
Bronchial Neoplasms, Carcinoma, Bronchogenic
Taipei, Taiwan
View Trial DetailsNCT06532032
Bronchial Neoplasms, Carcinoma, Bronchogenic
Irvine, California, United States
View Trial Details